82 related articles for article (PubMed ID: 22588675)
1. Continuous-flow synthesis of activated vitamin D3 and its analogues.
Fuse S; Mifune Y; Tanabe N; Takahashi T
Org Biomol Chem; 2012 Jul; 10(27):5205-11. PubMed ID: 22588675
[TBL] [Abstract][Full Text] [Related]
2. Continuous-flow synthesis of vitamin D3.
Fuse S; Tanabe N; Yoshida M; Yoshida H; Doi T; Takahashi T
Chem Commun (Camb); 2010 Dec; 46(46):8722-4. PubMed ID: 20877825
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of new 6-s-cis locked 1,2,25-trihydroxyprevitamin D3 analogues.
Sánchez-Abella L; Fernández S; Verstuyf A; Verlinden L; Ferrero M; Gotor V
Bioorg Med Chem; 2007 Jun; 15(12):4193-202. PubMed ID: 17412598
[TBL] [Abstract][Full Text] [Related]
4. Enantioselective synthesis of a key "A-ring" intermediate for the preparation of 1alpha-fluoro vitamin D3 analogues.
Giuffredi G; Bobbio C; Gouverneur V
J Org Chem; 2006 Jul; 71(14):5361-4. PubMed ID: 16808527
[TBL] [Abstract][Full Text] [Related]
5. The difference between 14-epi-previtamin D3 and 14-epi-19-norprevitamin D3: their synthesis and binding affinity for human VDR.
Sawada D; Katayama T; Tsukuda Y; Saito N; Saito H; Kakuda S; Takimoto-Kamimura M; Takenouchi K; Kittaka A
Anticancer Res; 2012 Jan; 32(1):319-26. PubMed ID: 22213322
[TBL] [Abstract][Full Text] [Related]
6. Fluoride-mediated elimination of allyl sulfones: application to the synthesis of a 2,4-dimethyl-A-ring vitamin D3 analogue.
Sikervar V; Fleet JC; Fuchs PL
J Org Chem; 2012 Jun; 77(11):5132-8. PubMed ID: 22533543
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, conformational analysis, and biological evaluation of 19-nor-vitamin D3 analogues with A-ring modifications.
Sánchez-Abella L; Fernández S; Verstuyf A; Verlinden L; Gotor V; Ferrero M
J Med Chem; 2009 Oct; 52(19):6158-62. PubMed ID: 19739672
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective Palladium-Catalyzed Approach to Vitamin D
Carballa D; Sigüeiro R; Rodríguez-Docampo Z; Zacconi F; Maestro MA; Mouriño A
Chemistry; 2018 Mar; 24(13):3314-3320. PubMed ID: 29239492
[TBL] [Abstract][Full Text] [Related]
9. Application of ring-closing metathesis to the synthesis of 19-functionalized derivatives of 1alpha-hydroxyvitamin D3.
Wojtkielewicz A; Morzycki JW
Org Lett; 2006 Mar; 8(5):839-42. PubMed ID: 16494454
[TBL] [Abstract][Full Text] [Related]
10. [1 alpha-hydroxyvitamin D3: chemical synthesis and biological effect].
Bauman VK; Bogoslovskiĭ NA; Kisel'nikova TA; Shakhova MK; Valinietse MIu
Prikl Biokhim Mikrobiol; 1978; 14(2):243-52. PubMed ID: 208064
[TBL] [Abstract][Full Text] [Related]
11. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion.
Brown AJ; Ritter CS; Weiskopf AS; Vouros P; Sasso GJ; Uskokovic MR; Wang G; Reddy GS
J Cell Biochem; 2005 Oct; 96(3):569-78. PubMed ID: 16088954
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel vitamin D3 analog with an additional ring annulated to A and seco-B rings.
Sokolowska K; Sicinski RR
Steroids; 2014 Sep; 87():67-75. PubMed ID: 24928728
[TBL] [Abstract][Full Text] [Related]
13. 25-Hydroxy[26,27-methyl-3H]vitamin D3-3 beta-(1,2-epoxypropyl)ether: an affinity labeling reagent for human vitamin D-binding protein.
Swamy N; Ray R
Arch Biochem Biophys; 1995 Jun; 319(2):504-7. PubMed ID: 7786034
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of a 3-position diastereomer of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71).
Hatakeyama S; Nagashima S; Imai N; Takahashi K; Ishihara J; Sugita A; Nihei T; Saito H; Takahashi F; Kubodera N
Bioorg Med Chem; 2006 Dec; 14(23):8050-6. PubMed ID: 16908172
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of previtamin D(3) analogues with A-ring modifications.
Sánchez-Abella L; Fernández S; Verstuyf A; Verlinden L; Gotor V; Ferrero M
Bioorg Med Chem; 2008 Dec; 16(24):10244-50. PubMed ID: 19006670
[TBL] [Abstract][Full Text] [Related]
16. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
[TBL] [Abstract][Full Text] [Related]
17. A general approach to the synthesis of enantiopure 19-nor-vitamin D3 and its C-2 phosphate analogs prepared from cyclohexadienyl sulfone.
Sikervar V; Fleet JC; Fuchs PL
Chem Commun (Camb); 2012 Sep; 48(72):9077-9. PubMed ID: 22852135
[TBL] [Abstract][Full Text] [Related]
18. The 2alpha-(3-hydroxypropyl) group as an active motif in vitamin D3 analogues as agonists of the mutant vitamin D receptor (Arg274Leu).
Honzawa S; Yamamoto Y; Yamashita A; Sugiura T; Kurihara M; Arai MA; Kato S; Kittaka A
Bioorg Med Chem; 2008 Mar; 16(6):3002-24. PubMed ID: 18248997
[TBL] [Abstract][Full Text] [Related]
19. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
